Study Evaluating Sirolimus in Kidney Transplant Recipients.

NCT00167947 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure
Graft vs Host Disease

Interventions

DRUG: Cyclosporine
DRUG: Steroids
DRUG: Rapamune (Sirolimus)

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer